BSE filing, NSE: BALMLAWRIE. Summary written from the filing by ALFA Finder's alert engine.
Balmer Lawrie & Company Ltd: key numbers
- Share price
- ₹154.80
- Market cap
- ₹2,647 Cr
- Revenue (annual)
- ₹2,717 Cr
- Net profit (annual)
- ₹276.6 Cr
- P/E (TTM)
- 9.5×Sector 21.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 2.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balmer Lawrie & Company Ltd
All →Balmer Lawrie & Company Management Change
Balmer Lawrie & Co. Ltd. has appointed Shri Durg Vijay Singh Deo as an Additional Non-Executive Independent Director, effective 22nd October, 2026.
Balmer Lawrie & Company Board Meeting Date
Balmer Lawrie intimated that its Board meets on 2 Nov 2026 to consider Q2/H1 FY27 unaudited results. The trading window closes until 48 hours after results declaration.
Balmer Lawrie & Company Legal & Regulatory
Balmer Lawrie & Co. Ltd. filed a writ petition before the Karnataka High Court challenging a GST appellate order related to tax demands for FY 2020-21.
Balmer Lawrie & Company Management Change
Balmer Lawrie & Company Ltd appointed Shri Aditya Shekhar Singh, Adv. Dominic Tadar, and CA Vivek Mittal as directors following approval at its 109th Annual General Meeting.
Balmer Lawrie & Company Results Update
Balmer Lawrie's 109th AGM press release reported FY2025-26 net turnover of Rs.2,784.60 Crore and profit before tax of Rs.330.87 Crore, citing robust operational performance.
Balmer Lawrie & Company Annual General Meeting
Balmer Lawrie & Co. Ltd. held its 109th Annual General Meeting on September 21, 2026. Shareholders considered ordinary and special business resolutions proposed in the agenda.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.